Resolution and SNR effects on carotid plaque classification

Raphael R Ronen1, Sharon E Clarke, Robert R Hammond

  • 1Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada.

Insights

Automatic plaque classification using multicontrast MRI is robust to resolution changes. Signal-to-noise ratio (SNR) is critical, with accuracy maintained until SNR drops significantly, showing applicability to in vivo imaging.

Area of Science:

  • Medical Imaging
  • Biomedical Engineering
  • Cardiovascular Research

Background:

  • Multicontrast-weighted MRI and automatic classification algorithms show promise for assessing plaque composition.
  • A gap exists in understanding how imaging conditions affect segmentation accuracy.

Purpose of the Study:

  • To investigate the impact of image resolution and signal-to-noise ratio (SNR) on the accuracy of automatic plaque classification.
  • To determine the robustness of multicontrast MRI-based plaque analysis under varying imaging conditions.

Main Methods:

  • Carotid endarterectomy samples (n=13) were imaged using proton density, T1, T2, and diffusion weightings at high resolution and SNR.
  • Maximum likelihood (ML) algorithm classified plaque components using contrast weighting intensities.
  • Image resolution and SNR were systematically degraded to assess classification accuracy.

Main Results:

  • Classification accuracy was independent of in-plane resolution from 156 microm to 1250 microm.
  • Accuracy was dependent on SNR, decreasing by less than 10% until SNR reached 25% of original values, then dropping sharply.
  • Automatic classifiers demonstrated robustness across a range of imaging conditions.

Conclusions:

  • Multicontrast MRI combined with automatic classification is a viable tool for plaque composition analysis.
  • The method is robust to resolution variations and moderately robust to SNR degradation, supporting its use in standard in vivo carotid imaging.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...